Christian Berdel

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

Viola Poeschel, Gerhard Held, Marita Ziepert et al. · The Lancet · 2019 · 253 citations · Full text

Medicine, Oncology, Cancer Immunology +10

Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation

Marcus Niewald, Christian Berdel, Jochen Fleckenstein et al. · Radiation Oncology · 2011 · 63 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Optimization of rituximab for the treatment of <scp>DLBCL</scp>: increasing the dose for elderly male patients

Michael Pfreundschuh, Niels Murawski, Samira Zeynalova et al. · British Journal of Haematology · 2017 · 55 citations · Full text

Pharmacy, Oncology, Pharmacokinetics +17

Radiotherapy (RT) to bulky (B) and extralymphatic (E) disease in combination with 6xR-CHOP-14 or R-CHOP-21 in young good-prognosis DLBCL patients: Results of the 2x2 randomized UNFOLDER trial of the DSHNHL/GLA.

Michael Pfreundschuh, Niels Murawski, Marita Ziepert et al. · Journal of Clinical Oncology · 2018 · 49 citations

Medicine, Oncology, Radiation Oncology +11

Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial

Gerhard Held, Lorenz Thurner, Viola Poeschel et al. · HemaSphere · 2023 · 16 citations · Full text

Medicine, Nuclear Medicine, Oncology +16